Reports for TEVA-OMEPRAZOLE
Brand name
TEVA-OMEPRAZOLE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02295415 |
Ingredients
OMEPRAZOLE |
Ingredient Strength
20 MG |
ATC Code
A02BC |
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-OMEPRAZOLE | 500 | Resolved | 2020-05-29 | 2020-06-11 | 116144 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2020-06-04 | 2020-06-11 | 116696 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2020-08-13 | 2020-12-03 | 122214 |
TEVA-OMEPRAZOLE | 500 | Resolved | 2020-08-27 | 2020-11-26 | 123090 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2021-10-21 | 2021-11-11 | 147711 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2022-01-20 | 2022-03-09 | 153177 |
TEVA-OMEPRAZOLE | 100M | Resolved | 2022-06-30 | 2023-04-28 | 163945 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2023-06-08 | 2023-08-18 | 194116 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2023-06-16 | 2023-07-05 | 195177 |
TEVA-OMEPRAZOLE | 100 & 500 | Resolved | 2024-01-25 | 2024-03-21 | 217226 |
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0